Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Positive Results from Six-Month Phase 2 Trial of Mavorixafor in ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Research shows some of the most common short-term effects include nausea, vomiting, abdominal pain, constipation, increased ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

People who have nausea, vomiting, diarrhea, stomach cramps or other symptoms ... immunocompromised people and others who have severe underlying chronic conditions. They should take extra ...

They can also slash risks of heart attack, stroke, and chronic disease ... to experience at least mild gastrointestinal ...

Study: Semaglutide in patients with overweight or obesity and chronic kidney disease without ... with gastrointestinal adverse events such as diarrhea and nausea more common in the semaglutide ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.

"If you don't have much interest in eating or sleeping so much you are missing meals, you are going to lose weight," ...

These cellular alterations can cause organ damage, leading to chronic diseases ... effects reported with curcumin include diarrhea, headache, rash, nausea, and yellow stool.